Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Cerevel Shareholders are encouraged to contact BFA Law about their rights relating to the upcoming merger.
-
Cerevel Shareholders are encouraged to contact BFA Law about their rights relating to the upcoming merger.
-
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
-
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
-
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
-
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
-
NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
-
NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
-
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
-
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If you...